Documents

Discussions Technicals Forecast Seasonals Options

Amylyx Pharmaceuticals, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Amylyx Pharmaceuticals, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Baird Global Healthcare Conference 2025

Sep 09, 2025

Transcript

Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 08, 2025

Transcript

Q2 2025

Aug 07, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Status Update

Jul 14, 2025

Slides

Press release

Investor Presentation

Jun 02, 2025

Slides

Q1 2025

May 08, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 12, 2025

Transcript

2024

Q4 2024

Mar 04, 2025

Transcript

Annual report10-K

Earnings release8-K

Q3 2024

Nov 07, 2024

Quarterly report10-Q

Earnings release8-K

Study Result

Oct 17, 2024

Slides

Study Result

Oct 17, 2024

Slides

Press release

Q2 2024

Aug 08, 2024

Quarterly report10-Q

Earnings release8-K

M&A Announcement

Jul 10, 2024

Press release

Slides

Q1 2024

May 09, 2024

Quarterly report10-Q

Earnings release8-K

Study Update

Apr 10, 2024

Press release

2023

Q4 2023

Feb 22, 2024

Annual report10-K

Earnings release8-K

Investor Presentation

Nov 27, 2023

Slides

Q3 2023

Nov 09, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 10, 2023

Quarterly report10-Q

Earnings release8-K

Status Update

Jul 26, 2023

Slides

Q1 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 13, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 10, 2022

Quarterly report10-Q

Earnings release8-K

FDA Announcement

Sep 30, 2022

Press release

Slides

2021

Q4 2021

Mar 31, 2022

Annual report10-K